Groff North America is looking forward to speaking at Cannabis Europa London, conference and expo, June 2022. Join me and influential leaders across politics, business & finance for two days of insights and networking; hosted in the historic Old Billingsgate, London. Secure your ticket now ➜  https://bit.ly/celondon #CannabisEuropa

Can DEA-backed cannabis growers strike gold via drug development? The cannabis industry hit a possible milestone in March when Bright Green Corp., a Florida company with “conditional” approval from the U.S. Drug Enforcement Administration to grow marijuana for research purposes, applied to list on the Nasdaq stock exchange. But the move also highlights the lofty […]

FOR IMMEDIATE RELEASE CONTACT: Amanda Peterson Martin apmartin@gavinadv.com 484-949-1320 Groff North America partners with Pennsylvania college for first-of-its-kind cannabinoid major Students will have access to products, internships to advance cannabis research, job training RED LION, Pa. – (March 24, 2022) – As the medicinal and recreational marijuana industries continue to grow, so does the need […]

How will Groff North America cannabis products be developed from research to market as medicines? CEO Joe Gryzb talked to Harri Leigh of WPMT FOX43 about the potential of the market and our first study Click Here to Watch

We are making history at Groff North America. After 53 years, we are one of five companies approved to grow and study cannabis for medical research in the U.S. WPMT FOX43 took a closer look at our role in ending the monopoly over federal legal cannabis production Click Here To Watch!

We know cannabis has powerful potential medical effects. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine. Click Here to Watch  Thank you @Harri Leigh of @WPMT FOX43 for highlighting our work.